MedPath

Intrathecal Morphine vs. Intrathecal Morphine and Regional Anesthesia After Cesarean Section.

Phase 4
Suspended
Conditions
Post-operative Pain
Interventions
Procedure: erector spinae plane block (ESP)
Drug: Duramorph
Drug: Ropivacaine
Drug: Bupivacaine Injection
Registration Number
NCT06114121
Lead Sponsor
University of Miami
Brief Summary

The objective of the study is to optimize post-operative analgesia and improve patient satisfaction while reducing total opioid consumption after cesarean section

Detailed Description

Not available

Recruitment & Eligibility

Status
SUSPENDED
Sex
Female
Target Recruitment
100
Inclusion Criteria

Not provided

Read More
Exclusion Criteria
  • Adults unable to consent
  • BMI>35
  • Individuals <18 years of age at time of admission
  • Individuals taking anticoagulant medications
  • Significant co-morbid disease of pregnancy (including: gestational diabetes and significant abnormal placentation)
  • Pre-existing chronic pain or pain disorder diagnosis
  • Conversion from neuraxial to general anesthesia
  • Prisoners
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
erector spinae plane blockBupivacaine Injectionparticipants will be in this group for up to 9 months and receive erector spinae plane (ESP) block
erector spinae plane blockerector spinae plane block (ESP)participants will be in this group for up to 9 months and receive erector spinae plane (ESP) block
standard of careBupivacaine Injectionparticipants in this group will receive the standard of care treatment and will be in this group for up to 9 months.
erector spinae plane blockRopivacaineparticipants will be in this group for up to 9 months and receive erector spinae plane (ESP) block
standard of careRopivacaineparticipants in this group will receive the standard of care treatment and will be in this group for up to 9 months.
erector spinae plane blockDuramorphparticipants will be in this group for up to 9 months and receive erector spinae plane (ESP) block
standard of careDuramorphparticipants in this group will receive the standard of care treatment and will be in this group for up to 9 months.
Primary Outcome Measures
NameTimeMethod
post-operative opioid analgesic medicationup to 24 hours

measurement (milligrams)

Secondary Outcome Measures
NameTimeMethod
change in post-operative pain medication by visual analog scalebaseline, up to 24 hours

Patient administered instrument to indicate pain on a level from 0 to10. (0: no pain. 10: worst imaginable pain)

number of minutes to first use of rescue medicationup to 24 hours

the number of minutes calculated using the kaplan-meier. Calculated using the number of patients that did not need the rescue analgesic at the start of each day post-surgery, and the number of patients who needed the rescue analgesic.

obstetric quality of recovery scaleup to 24 hours

responses range from 0-10. zero is strongly agree, strongly disagree.

Trial Locations

Locations (1)

University of Miami

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath